Shandong Weigao Medical Polymer Net Acquisitions/Divestitures 2012-2024 | SHWGF
Shandong Weigao Medical Polymer net acquisitions/divestitures from 2012 to 2024. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
| Shandong Weigao Medical Polymer Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2023 | $-6 |
| 2022 | $4 |
| 2021 | $-2 |
| 2020 | $0 |
| 2019 | $-3 |
| 2018 | $-819 |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| 2014 | $N/A |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||